Southampton, PA, United States of America

Martin Lock

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Martin Lock in Gene Therapy

Introduction

Martin Lock, an inventive mind based in Southampton, PA, has made significant contributions to the field of gene therapy through his twelve patents. His expertise in scalable purification methods has positioned him as a key figure in advancing recombinant adeno-associated virus (rAAV) vector technologies.

Latest Patents

Among his latest patents, Martin's work on scalable purification methods for AAV1 and AAV9 has garnered attention. Both patents describe a two-step chromatography purification scheme that effectively captures and isolates genome-containing rAAV vector particles from the clarified, concentrated supernatant of rAAV production cell cultures. The process leverages an affinity capture method conducted at high salt concentration, followed by an anion exchange resin method performed at high pH. As a result, this innovative method produces rAAV vector particles that are substantially free of rAAV intermediates, underscoring the importance of his work in enhancing the efficiency and efficacy of gene therapies.

Career Highlights

Martin Lock has gained valuable experience during his career, notably at the University of Pennsylvania. His work there has contributed to the understanding and development of advanced purification techniques crucial for gene therapy applications. His portfolio of patents reflects his dedication to addressing complex challenges in the biotechnology field.

Collaborations

Throughout his career, Martin Lock has collaborated with talented individuals such as Mauricio R. Alvira and Luc H. Vandenberghe. These partnerships have undoubtedly facilitated the exchange of innovative ideas and advances in research, further enriching the field of gene therapy.

Conclusion

Martin Lock's contributions to the field of genetic research and innovation are noteworthy. His twelve patents, particularly those focused on scalable purification methods for rAAV, demonstrate his commitment to improving gene therapy technologies. With a solid foundation of collaboration and experience, Martin continues to influence the biotechnology landscape, making strides that could impact countless lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…